Lezatis Tablet

Przegląd produktu

About Lezatis Tablet

Lezatis Tablet is a medication containing the active ingredient Deflazacort, classified as Pharmaceutical drug. Deflazacort, sold under the brand name Calcort among others, is a glucocorticoid belonging to acetonides or O-isopropylidene derivative. It is used as an anti-inflammatory and was patented in 1969 and approved for medical use in 1985.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Deflazacort, the active ingredient in Lezatis Tablet, belongs to the Pharmaceutical drug class. 1 INDICATIONS AND USAGE Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Lezatis Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Lezatis Tablet for extended periods without medical advice.